
The basis of allotment for the ₹920 crore Park Medi World IPO will be announced today, 15 December 2025. The bidding window was open from December 10, 2025, to December 12, 2025, during which the IPO received a total subscription of 8.10x
The Park Medi World IPO is a book-building issue of ₹920 crore, consisting of a fresh issue of ₹770 crore and an offer for sale (OFS) of ₹150 crore. The price band is set between ₹154 and ₹162 per share.
The booking-running lead managers for the IPO are Nuvama Wealth Management Limited, CLSA India Private Limited, DAM Capital Advisors Limited, and Intensive Fiscal Services Private Limited. At the same time, KFin Technologies Limited is the registrar for the issue.
The net proceeds from the fresh issue will be used towards the following objectives:
As per media reports, the Grey Market Premium (GMP) of Park Medi World is reported at ₹6.5 over the IPO price.
[12-December-2025 19:00:00 hrs]
|
Investor Category |
Subscription (Times) |
|
Qualified Institutional Buyers (QIBs) |
11.48 |
|
Non-Institutional Investors |
15.15 |
|
Retail Individual Investors (RIIs) |
3.16 |
|
Total |
8.10 |
Park Medi World is one of North India’s leading private healthcare providers, operating a growing network of advanced multi-super speciality hospitals. Their portfolio comprises 14 NABH-accredited hospitals, of which eight also hold NABL certification, with a total capacity of nearly 3,000 beds across the region.
Disclaimer: This news is solely for educational purposes. The securities/investments quoted here are not recommendatory.
To read the RA disclaimer, please click here.